BioSpace News Archive

Medpace Holdings, Inc. announced that it will report its first quarter 2018 financial results after the market close on Monday, April 30, 2018.

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, subject to Amneal and Impax’s agreement to divest certain products.

HMC HealthWorks has named John McHugh to be its Chief Pharmacy Officer (CPO). McHugh arrived to the company from OptumRx.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology.

The ITTS (Instituto de Tecnologias para o Trânsito Seguro - ‘Institute for Safe Traffic Technologies’) and the Brazilian mission at the UN are convening a congress at United Nations headquarters in New York, to present to the world the results of a program that has been saving lives on Brazilian highways for the past two years.

The Academy of Managed Care Pharmacy (AMCP) Foundation is pleased to announce winners of its 18th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition.

Bovie Medical announced that financial results for the first quarter of fiscal year 2018 will be released after the market closes on Monday, May 14.

A coalition of four leading patient advocacy and health care provider organizations, including the American Diabetes Association (ADA), presented testimony to California lawmakers urging them to ensure people with diabetes who receive their health care coverage from Medi-Cal have access to the life-saving medical technology known as continuous glucose monitors (CGMs).

Warriors and their guests gathered to hike the challenging Usery Mountain Wind Cave trail and learn how to dine out nutritionally during a recent Wounded Warrior Project® (WWP) event designed to promote physical wellness and mental health.

Inari Medical, Inc., announced today the presentation of results from its FlowTriever Pulmonary Embolectomy (“FLARE”) Clinical Study that evaluated the safety and effectiveness of the FlowTriever Retrieval/Aspiration System for the treatment of pulmonary embolism (“PE”).